{"id":3726,"date":"2025-04-22T08:39:01","date_gmt":"2025-04-22T07:39:01","guid":{"rendered":"https:\/\/movianto.com\/es\/?post_type=news&#038;p=3726"},"modified":"2025-04-22T08:39:01","modified_gmt":"2025-04-22T07:39:01","slug":"confronting-challenges-in-europes-largest-pharma-market","status":"publish","type":"news","link":"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/","title":{"rendered":"Afrontar los retos del mayor mercado farmac\u00e9utico de Europa: Entrevista con Dennis Spamer, director general de Movianto DACH"},"excerpt":{"rendered":"En esta entrevista, hace hincapi\u00e9 en el enfoque estrat\u00e9gico y la delegaci\u00f3n, y comparte sus conocimientos sobre el mercado sanitario de la regi\u00f3n DACH y sus retos.","protected":false},"featured_media":3727,"parent":0,"template":"","acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v24.5) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Afrontar los retos del mayor mercado farmac\u00e9utico de Europa: Entrevista con Dennis Spamer, director general de Movianto DACH - ES<\/title>\n<meta name=\"description\" content=\"En esta entrevista, hace hincapi\u00e9 en el enfoque estrat\u00e9gico y la delegaci\u00f3n, y comparte sus conocimientos sobre el mercado sanitario de la regi\u00f3n DACH y sus retos.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Afrontar los retos del mayor mercado farmac\u00e9utico de Europa: Entrevista con Dennis Spamer, director general de Movianto DACH\" \/>\n<meta property=\"og:description\" content=\"En esta entrevista, hace hincapi\u00e9 en el enfoque estrat\u00e9gico y la delegaci\u00f3n, y comparte sus conocimientos sobre el mercado sanitario de la regi\u00f3n DACH y sus retos.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/\" \/>\n<meta property=\"og:site_name\" content=\"ES\" \/>\n<meta property=\"og:image\" content=\"https:\/\/movianto.com\/es\/wp-content\/uploads\/sites\/5\/2025\/04\/ETPTPI-YouTube.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/\",\"url\":\"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/\",\"name\":\"Afrontar los retos del mayor mercado farmac\u00e9utico de Europa: Entrevista con Dennis Spamer, director general de Movianto DACH - ES\",\"isPartOf\":{\"@id\":\"https:\/\/movianto.com\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/movianto.com\/es\/wp-content\/uploads\/sites\/5\/2025\/04\/ETPTPI-YouTube.jpg\",\"datePublished\":\"2025-04-22T07:39:01+00:00\",\"description\":\"En esta entrevista, hace hincapi\u00e9 en el enfoque estrat\u00e9gico y la delegaci\u00f3n, y comparte sus conocimientos sobre el mercado sanitario de la regi\u00f3n DACH y sus retos.\",\"breadcrumb\":{\"@id\":\"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/#primaryimage\",\"url\":\"https:\/\/movianto.com\/es\/wp-content\/uploads\/sites\/5\/2025\/04\/ETPTPI-YouTube.jpg\",\"contentUrl\":\"https:\/\/movianto.com\/es\/wp-content\/uploads\/sites\/5\/2025\/04\/ETPTPI-YouTube.jpg\",\"width\":1280,\"height\":720,\"caption\":\"Dennis Spamer portrait shoulders up smiles at the camera with the Movianto logo next to him\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/movianto.com\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Afrontar los retos del mayor mercado farmac\u00e9utico de Europa: Entrevista con Dennis Spamer, director general de Movianto DACH\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/movianto.com\/es\/#website\",\"url\":\"https:\/\/movianto.com\/es\/\",\"name\":\"ES\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/movianto.com\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/movianto.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/movianto.com\/es\/#organization\",\"name\":\"ES\",\"url\":\"https:\/\/movianto.com\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/movianto.com\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/movianto.com\/es\/wp-content\/uploads\/sites\/5\/2023\/03\/Movianto-news-photos-9.jpg\",\"contentUrl\":\"https:\/\/movianto.com\/es\/wp-content\/uploads\/sites\/5\/2023\/03\/Movianto-news-photos-9.jpg\",\"width\":600,\"height\":424,\"caption\":\"ES\"},\"image\":{\"@id\":\"https:\/\/movianto.com\/es\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Afrontar los retos del mayor mercado farmac\u00e9utico de Europa: Entrevista con Dennis Spamer, director general de Movianto DACH - ES","description":"En esta entrevista, hace hincapi\u00e9 en el enfoque estrat\u00e9gico y la delegaci\u00f3n, y comparte sus conocimientos sobre el mercado sanitario de la regi\u00f3n DACH y sus retos.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/","og_locale":"en_GB","og_type":"article","og_title":"Afrontar los retos del mayor mercado farmac\u00e9utico de Europa: Entrevista con Dennis Spamer, director general de Movianto DACH","og_description":"En esta entrevista, hace hincapi\u00e9 en el enfoque estrat\u00e9gico y la delegaci\u00f3n, y comparte sus conocimientos sobre el mercado sanitario de la regi\u00f3n DACH y sus retos.","og_url":"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/","og_site_name":"ES","og_image":[{"width":1280,"height":720,"url":"https:\/\/movianto.com\/es\/wp-content\/uploads\/sites\/5\/2025\/04\/ETPTPI-YouTube.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/","url":"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/","name":"Afrontar los retos del mayor mercado farmac\u00e9utico de Europa: Entrevista con Dennis Spamer, director general de Movianto DACH - ES","isPartOf":{"@id":"https:\/\/movianto.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/#primaryimage"},"image":{"@id":"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/#primaryimage"},"thumbnailUrl":"https:\/\/movianto.com\/es\/wp-content\/uploads\/sites\/5\/2025\/04\/ETPTPI-YouTube.jpg","datePublished":"2025-04-22T07:39:01+00:00","description":"En esta entrevista, hace hincapi\u00e9 en el enfoque estrat\u00e9gico y la delegaci\u00f3n, y comparte sus conocimientos sobre el mercado sanitario de la regi\u00f3n DACH y sus retos.","breadcrumb":{"@id":"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/#primaryimage","url":"https:\/\/movianto.com\/es\/wp-content\/uploads\/sites\/5\/2025\/04\/ETPTPI-YouTube.jpg","contentUrl":"https:\/\/movianto.com\/es\/wp-content\/uploads\/sites\/5\/2025\/04\/ETPTPI-YouTube.jpg","width":1280,"height":720,"caption":"Dennis Spamer portrait shoulders up smiles at the camera with the Movianto logo next to him"},{"@type":"BreadcrumbList","@id":"https:\/\/movianto.com\/es\/noticias\/confronting-challenges-in-europes-largest-pharma-market\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/movianto.com\/es\/"},{"@type":"ListItem","position":2,"name":"Afrontar los retos del mayor mercado farmac\u00e9utico de Europa: Entrevista con Dennis Spamer, director general de Movianto DACH"}]},{"@type":"WebSite","@id":"https:\/\/movianto.com\/es\/#website","url":"https:\/\/movianto.com\/es\/","name":"ES","description":"","publisher":{"@id":"https:\/\/movianto.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/movianto.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/movianto.com\/es\/#organization","name":"ES","url":"https:\/\/movianto.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/movianto.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/movianto.com\/es\/wp-content\/uploads\/sites\/5\/2023\/03\/Movianto-news-photos-9.jpg","contentUrl":"https:\/\/movianto.com\/es\/wp-content\/uploads\/sites\/5\/2023\/03\/Movianto-news-photos-9.jpg","width":600,"height":424,"caption":"ES"},"image":{"@id":"https:\/\/movianto.com\/es\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/movianto.com\/es\/wp-json\/wp\/v2\/news\/3726"}],"collection":[{"href":"https:\/\/movianto.com\/es\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/movianto.com\/es\/wp-json\/wp\/v2\/types\/news"}],"version-history":[{"count":2,"href":"https:\/\/movianto.com\/es\/wp-json\/wp\/v2\/news\/3726\/revisions"}],"predecessor-version":[{"id":3731,"href":"https:\/\/movianto.com\/es\/wp-json\/wp\/v2\/news\/3726\/revisions\/3731"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/movianto.com\/es\/wp-json\/wp\/v2\/media\/3727"}],"wp:attachment":[{"href":"https:\/\/movianto.com\/es\/wp-json\/wp\/v2\/media?parent=3726"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}